Press Releases

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel Go

Month Year

Su	Mo	Tu	We	Th	Fr	Sa
25	26	27	28	29	30	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31	1	2	3	4	5

Cancel Go

Get News Alerts by Email

Year All Years 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Keywords Go

Advanced Search

Search

  Search Headlines Only

From

To

Asset Types

 Video  Audio  Photos  Documents  Events  Standard

 Basic Search

• Sep 26, 2023

  Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy
• Sep 5, 2023

  Cardiff Oncology to Present at Upcoming Investor Conferences in September
• Aug 9, 2023

  Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business Update
• Aug 7, 2023

  Cardiff Oncology Announces New Lead Program in First-Line Metastatic Colorectal Cancer and Expanded Pfizer Relationship
• Jul 24, 2023

  Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• Jun 20, 2023

  Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• Jun 5, 2023

  Cardiff Oncology to Present at the Jefferies Healthcare Conference
• May 4, 2023

  Cardiff Oncology Reports First-Quarter 2023 Results and Provides Business Update
• Mar 28, 2023

  Cardiff Oncology Announces First Patient Dosed in ONSEMBLE Phase 2 Randomized Trial of Onvansertib in Patients with Metastatic Colorectal Cancer
• Mar 6, 2023

  Cardiff Oncology Formally Introduces Scientific Advisory Board
• Mar 2, 2023

  Cardiff Oncology Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update
• Feb 27, 2023

  Cardiff Oncology to Present at the Cowen 43rd Annual Health Care Conference
• 
  Feb 2, 2023

  Cardiff Oncology Announces the Appointment of Fairooz Kabbinavar, MD, FACP, as Chief Medical Officer

  • Photos 1
• Jan 10, 2023

  Cardiff Oncology to Present at B. Riley Securities' 3rd Annual Oncology Conference
• Nov 21, 2022

  Cardiff Oncology to Present at Upcoming Investor Conferences
• Nov 8, 2022

  Cardiff Oncology to Present at the Jefferies London Healthcare Conference
• Nov 3, 2022

  Cardiff Oncology Reports Third Quarter 2022 Results and Provides Business Updates
• Sep 12, 2022

  Cardiff Oncology Announces Plans for a Randomized Trial in Metastatic Colorectal Cancer (mCRC), Durability of Responses in Ongoing Phase 1b/2 Trial in mCRC and Additional Business Updates
• Sep 10, 2022

  Cardiff Oncology Announces New Preclinical and Clinical Data from Program in KRAS-mutated Metastatic Colorectal Cancer (mCRC) at the ESMO Congress 2022
• Sep 8, 2022

  Cardiff Oncology to Present at Upcoming Investor Conferences in September
• Sep 6, 2022

  Cardiff Oncology Announces Upcoming Poster Presentations at the ESMO Congress 2022
• Aug 29, 2022

  Cardiff Oncology to Host Webcast and Conference Call to Provide a Clinical and Corporate Update on September 12, 2022
• Aug 4, 2022

  Cardiff Oncology Reports Second Quarter 2022 Results and Provides Business Updates
• Jul 5, 2022

  Cardiff Oncology to Present at the William Blair Biotech Focus Conference 2022
• May 17, 2022

  Cardiff Oncology to Present at the H.C. Wainwright Global Investment Conference

Show 5102550100 per page